Marshall Wace, LLP Health Catalyst, Inc. Transaction History

Marshall Wace, LLP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$9.3 - $18.27 $988,208 - $1.94 Million	-106,259 Reduced 86.94%	15,969 $155,000
Q2 2022 Aug 15, 2022	BUY	$11.79 - $27.63 $1.44 Million - $3.38 Million	122,228 New	122,228 $1.77 Million
Q4 2021 Feb 14, 2022	SELL	$36.68 - $54.02 $2.69 Million - $3.96 Million	-73,321 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$49.57 - $58.15 $3.63 Million - $4.26 Million	73,321 New	73,321 $3.67 Million
Q2 2021 Aug 13, 2021	SELL	$47.17 - $58.64 $25.7 Million - $31.9 Million	-544,171 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$42.51 - $54.07 $16.4 Million - $20.9 Million	-386,015 Reduced 41.5%	544,171 $25.5 Million
Q4 2020 Feb 16, 2021	BUY	$31.9 - $44.89 $2.25 Million - $3.16 Million	70,456 Added 8.2%	930,186 $40.5 Million
Q3 2020 Nov 16, 2020	SELL	$28.55 - $36.91 $1.54 Million - $1.99 Million	-54,023 Reduced 5.91%	859,730 $31.5 Million
Q2 2020 Aug 13, 2020	SELL	$24.0 - $32.87 $2.56 Million - $3.5 Million	-106,605 Reduced 10.45%	913,753 $26.7 Million
Q1 2020 May 15, 2020	BUY	$17.8 - $37.6 $18.2 Million - $38.4 Million	1,020,358 New	1,020,358 $26.7 Million

165

50.2M

2.51M

1.8K

Ticker HCAT
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 54,723,400
Market Cap $425M
Description
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its offerings include data and analytics platform, a commercial-grade data and analytics platform for the healthcare sector; AI and data science, providing integration of AI into existing business intelligence tools, increasing analytics accura...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.